The aim of this study was to investigate liver steatosis and the potential for liver fibrosis development in patients with newly diagnosed acromegaly, using QUS techniques (TAI and SWE) and biochemical markers (CK18 and IGFBP7). This evidence concerns the gene IGFBP7 and fatty liver disease.